MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections

Cong B, Martin TA, Cao X, Ruge FS, Li AX, Mansel RE, Wang Y, Jiang WG

Breast Cancer: Targets and Therapy 2026, 18:565199

Published Date: 14 January 2026